Inform Genomics
Curated by SignalProvider of pharmacogenomics tools for cancer
Overview
Provider of pharmacogenomics tools for cancer. The cloud-based platform uses advanced machine-learning algorithms to correlate interactions of SNPs and genes to predict clinical outcomes. It is developing two products. The first attempts to analyze patient genomic data and predict the percentage of patients receiving hematopoeitic stem cell transplants who will develop oral mucositis as a side-effect. The other product OnPART (Oncology Preferences And Risk of Toxicity) uses patient genomic data to predict response to chemotherapy and can be used by oncologists to pick the most effective chemotherapy agents for solid tumors.
Key facts
- Founded
- 2010
- Headquarters
- Boston, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- Commercial model
- Sign up to view